Solstice Advanced Materials Inc. (SOLS)
Chemicals & Allied Products · Healthcare · $13.3B
Intrinsic Value (Consensus)
$17.76
Current Price
$83.56
Margin of Safety
-78.7%
78.7% Above Intrinsic Value
Value: $18
Price: $84
Valuation Model Estimates
Current Price: $83.56
DCF (Discounted Cash Flow)
$9.50
Graham Number
$17.26
Earnings Power Value
$14.47
Relative Value (P/E)
$29.80
Dividend Discount Model
Not applicable
—
Consensus Value
$17.76
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
51
Profitability
22/25
Strength
15/25
Valuation
7/25
Growth
7/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 142%
Key Financials
- EPS (TTM)
- $1.49
- EPS (Forward)
- $1.52
- Book Value
- $8.89
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 16.8%
- Debt/Equity
- 142%
- Revenue Growth
- 3.1%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance